Latest news for Tong Ren Tang (OTC:TGRNF) Stock

Tong Ren Tang Technologies Co Ltd is engaged in the production and distribution of Chinese medicine and predominantly operates in Mainland China and Hong Kong. The operating segments derive their revenue predominantly from the manufacture and sale of Chinese medicine of the company in Mainland China and Tong Ren Tang Chinese Medicine and its subsidiaries engaged in manufacturing, retail, and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments outside Mainland China and wholesale of healthcare products in Mainland China.

TONG REN TANG TECHS by Tong Ren Tang Technologies

Tong Ren Tang Technologies Co Ltd

Tong Ren Tang Technologies Co. Ltd. Non-GAAP EPS of C$0.43, revenue of C$23.89M

Tong Ren Tang Technologies Co. Ltd. revenue of RMB6.77B

Tong Ren Tang Technologies Co (HK:1666) has released an update. Tong Ren Tang Technologies Co. Ltd. has announced a final dividend of RMB 0.18 per ...

Tong Ren Tang Announces Final 2023 Dividend

Tong Ren Tang Technologies Co (HK:1666) has released an update. Tong Ren Tang Technologies Co. Ltd., a prominent player in China's pharmaceutical i...

Tong Ren Tang Announces Updated Board Structure

Tong Ren Tang Technologies Co (HK:1666) has released an update. Tong Ren Tang Technologies Co. Ltd successfully held its 2023 Annual General Meetin...

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

Tong Ren Tang

News

Latest news for Tong Ren Tang (OTC:TGRNF) Stock